CIC
ALXN

Cornercap Investment Counsel’s Alexion Pharmaceuticals ALXN Stock Holding History

Cornercap Investment Counsel’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,469
Closed -$454K – 630
2021
Q2 		$454K Sell
2,469
-295
-11% -$50.6K 0.05% 486
2021
Q1 		$423K Sell
2,764
-25,027
-90% -$3.87M 0.05% 480
2020
Q4 		$3.01M Sell
27,791
-2,137
-7% -$275K 0.43% 72
2020
Q3 		$3.42M Sell
29,928
-733
-2% -$79.1K 0.48% 45
2020
Q2 		$3.44M Sell
30,661
-621
-2% -$65.9K 0.56% 39
2020
Q1 		$2.81M Buy
31,282
+73
+0.2% +$7.16K 0.55% 45
2019
Q4 		$3.38M Buy
31,209
+624
+2% +$66.7K 0.45% 68
2019
Q3 		$3M Buy
30,585
+7,080
+30% +$798K 0.42% 81
2019
Q2 		$3.08M Buy
23,505
+8,185
+53% +$1.05M 0.41% 82
2019
Q1 		$2.07M Buy
+15,320
New +$1.9M 0.29% 109
2018
Q1 		– Sell
-14,545
Closed -$1.74M – 463
2017
Q4 		$1.74M Buy
+14,545
New +$1.77M 0.24% 124

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Cornercap Investment Counsel's ALXN Position: Q3 2021 in Review

Cornercap Investment Counsel sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 2,469 shares — an estimated $454K sold.

Cornercap Investment Counsel first reported a position in ALXN in Q4 2017 and held it in 11 quarters. The position peaked at $3.44M in Q2 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Cornercap Investment Counsel reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Cornercap Investment Counsel sold 2,469 Alexion Pharmaceuticals shares in Q3 2021, an estimated $454K.
  • Cornercap Investment Counsel first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 11 quarters.
  • Cornercap Investment Counsel's Alexion Pharmaceuticals position peaked at $3.44M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Cornercap Investment Counsel's 13F filing for Q3 2021, filed 15 Nov 2021.